US Stock MarketDetailed Quotes

SLNCF SILENCE THERAPEUTICS PLC

Watchlist
  • 5.500
  • -0.300-5.17%
15min DelayClose Nov 1 16:00 ET
772.16MMarket Cap-13033P/E (TTM)

SILENCE THERAPEUTICS PLC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-93.43%598K
9.07%12.41M
44.99%25.38M
-55.95%2.1M
-17.00%2.8M
149.90%9.1M
98.78%11.37M
40.97%17.5M
39.57%4.77M
6.81%3.37M
Operating revenue
-93.43%598K
9.07%12.41M
44.99%25.38M
-55.95%2.1M
-17.00%2.8M
149.90%9.1M
98.78%11.37M
40.97%17.5M
39.57%4.77M
6.81%3.37M
Cost of revenue
-6.82%2.64M
-51.19%2.21M
-5.17%10.32M
-65.12%1.35M
-32.87%1.61M
20.37%2.83M
99.30%4.53M
45.92%10.88M
88.98%3.86M
16.67%2.39M
Gross profit
-132.52%-2.04M
49.02%10.19M
127.41%15.06M
-16.89%753K
21.90%1.19M
385.90%6.27M
98.43%6.84M
33.51%6.62M
-33.97%906K
-11.50%977K
Operating expense
-8.16%16.28M
-24.44%14.35M
17.11%64.66M
18.41%14.05M
-4.85%13.89M
15.28%17.73M
42.04%18.99M
8.75%55.21M
-6.08%11.87M
9.04%14.6M
Selling and administrative expenses
3.38%5.29M
-19.84%5.17M
5.24%20.64M
18.66%4.12M
-14.95%4.96M
12.47%5.12M
11.86%6.45M
-1.99%19.61M
-35.91%3.47M
6.49%5.83M
-General and administrative expense
3.38%5.29M
-19.84%5.17M
5.24%20.64M
18.66%4.12M
-14.95%4.96M
12.47%5.12M
11.86%6.45M
-1.99%19.61M
-35.91%3.47M
6.49%5.83M
Research and development costs
-12.84%11M
-26.80%9.18M
23.65%44.03M
18.31%9.94M
1.86%8.93M
16.46%12.62M
64.92%12.54M
15.73%35.61M
16.27%8.4M
10.80%8.77M
Operating profit
-59.93%-18.32M
65.79%-4.16M
-2.08%-49.6M
-21.33%-13.3M
6.77%-12.7M
18.68%-11.46M
-22.45%-12.15M
-6.07%-48.59M
2.68%-10.96M
-10.88%-13.62M
Net non-operating interest income expense
259.49%882K
250.95%791K
688.83%1.41M
108.78%451K
-52.55%2.04M
-182.66%-553K
-249.71%-524K
8,850.00%179K
-6,518.75%-5.14M
1,751.29%4.3M
Non-operating interest income
213.24%1.07M
139.29%804K
539.82%1.45M
107.58%388K
-52.74%2.05M
-49.18%340K
-4.00%336K
2,160.00%226K
-256,200.00%-5.12M
1,362.50%4.33M
Non-operating interest expense
-79.51%183K
-98.49%13K
-27.66%34K
-584.62%-63K
-76.47%8K
--893K
--860K
487.50%47K
116.67%13K
-46.88%34K
Other net income (expense)
-302.49%-2.12M
2,477.27%1.05M
Gain on sale of security
----
----
-302.49%-2.12M
----
----
----
----
2,477.27%1.05M
----
----
Income before tax
-45.22%-17.44M
73.45%-3.37M
-6.21%-50.31M
0.56%-14.97M
-14.31%-10.66M
10.51%-12.01M
-32.40%-12.67M
-3.30%-47.37M
-34.05%-15.05M
22.62%-9.33M
Income tax
-16.78%-1.88M
39.69%-1.49M
-2.38%-7.04M
56.95%-554K
-8.46%-2.41M
-8.64%-1.61M
-30.77%-2.47M
-6.72%-6.88M
28.22%-1.29M
-4.71%-2.22M
Net income
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
Net income continuous Operations
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
Minority interest income
Net income attributable to the parent company
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-49.62%-15.56M
81.62%-1.88M
-6.86%-43.27M
-4.72%-14.41M
-16.15%-8.25M
12.88%-10.4M
-32.80%-10.2M
-2.74%-40.49M
-45.89%-13.76M
28.46%-7.1M
Basic earnings per share
-15.63%-0.111
85.26%-0.014
7.16%-0.389
4.58%-0.125
-2.78%-0.074
27.82%-0.096
-10.47%-0.095
5.42%-0.419
-24.76%-0.131
35.14%-0.072
Diluted earnings per share
-15.63%-0.111
85.26%-0.014
7.16%-0.389
4.58%-0.125
-2.78%-0.074
27.82%-0.096
-10.47%-0.095
5.42%-0.419
-24.76%-0.131
35.14%-0.072
Dividend per share
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -93.43%598K9.07%12.41M44.99%25.38M-55.95%2.1M-17.00%2.8M149.90%9.1M98.78%11.37M40.97%17.5M39.57%4.77M6.81%3.37M
Operating revenue -93.43%598K9.07%12.41M44.99%25.38M-55.95%2.1M-17.00%2.8M149.90%9.1M98.78%11.37M40.97%17.5M39.57%4.77M6.81%3.37M
Cost of revenue -6.82%2.64M-51.19%2.21M-5.17%10.32M-65.12%1.35M-32.87%1.61M20.37%2.83M99.30%4.53M45.92%10.88M88.98%3.86M16.67%2.39M
Gross profit -132.52%-2.04M49.02%10.19M127.41%15.06M-16.89%753K21.90%1.19M385.90%6.27M98.43%6.84M33.51%6.62M-33.97%906K-11.50%977K
Operating expense -8.16%16.28M-24.44%14.35M17.11%64.66M18.41%14.05M-4.85%13.89M15.28%17.73M42.04%18.99M8.75%55.21M-6.08%11.87M9.04%14.6M
Selling and administrative expenses 3.38%5.29M-19.84%5.17M5.24%20.64M18.66%4.12M-14.95%4.96M12.47%5.12M11.86%6.45M-1.99%19.61M-35.91%3.47M6.49%5.83M
-General and administrative expense 3.38%5.29M-19.84%5.17M5.24%20.64M18.66%4.12M-14.95%4.96M12.47%5.12M11.86%6.45M-1.99%19.61M-35.91%3.47M6.49%5.83M
Research and development costs -12.84%11M-26.80%9.18M23.65%44.03M18.31%9.94M1.86%8.93M16.46%12.62M64.92%12.54M15.73%35.61M16.27%8.4M10.80%8.77M
Operating profit -59.93%-18.32M65.79%-4.16M-2.08%-49.6M-21.33%-13.3M6.77%-12.7M18.68%-11.46M-22.45%-12.15M-6.07%-48.59M2.68%-10.96M-10.88%-13.62M
Net non-operating interest income expense 259.49%882K250.95%791K688.83%1.41M108.78%451K-52.55%2.04M-182.66%-553K-249.71%-524K8,850.00%179K-6,518.75%-5.14M1,751.29%4.3M
Non-operating interest income 213.24%1.07M139.29%804K539.82%1.45M107.58%388K-52.74%2.05M-49.18%340K-4.00%336K2,160.00%226K-256,200.00%-5.12M1,362.50%4.33M
Non-operating interest expense -79.51%183K-98.49%13K-27.66%34K-584.62%-63K-76.47%8K--893K--860K487.50%47K116.67%13K-46.88%34K
Other net income (expense) -302.49%-2.12M2,477.27%1.05M
Gain on sale of security ---------302.49%-2.12M----------------2,477.27%1.05M--------
Income before tax -45.22%-17.44M73.45%-3.37M-6.21%-50.31M0.56%-14.97M-14.31%-10.66M10.51%-12.01M-32.40%-12.67M-3.30%-47.37M-34.05%-15.05M22.62%-9.33M
Income tax -16.78%-1.88M39.69%-1.49M-2.38%-7.04M56.95%-554K-8.46%-2.41M-8.64%-1.61M-30.77%-2.47M-6.72%-6.88M28.22%-1.29M-4.71%-2.22M
Net income -49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M
Net income continuous Operations -49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M
Minority interest income
Net income attributable to the parent company -49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -49.62%-15.56M81.62%-1.88M-6.86%-43.27M-4.72%-14.41M-16.15%-8.25M12.88%-10.4M-32.80%-10.2M-2.74%-40.49M-45.89%-13.76M28.46%-7.1M
Basic earnings per share -15.63%-0.11185.26%-0.0147.16%-0.3894.58%-0.125-2.78%-0.07427.82%-0.096-10.47%-0.0955.42%-0.419-24.76%-0.13135.14%-0.072
Diluted earnings per share -15.63%-0.11185.26%-0.0147.16%-0.3894.58%-0.125-2.78%-0.07427.82%-0.096-10.47%-0.0955.42%-0.419-24.76%-0.13135.14%-0.072
Dividend per share
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data